{"id":4466,"date":"2025-09-16T11:47:52","date_gmt":"2025-09-16T11:47:52","guid":{"rendered":"https:\/\/gvalex.it\/?post_type=track-record&#038;p=4466"},"modified":"2025-09-16T11:48:55","modified_gmt":"2025-09-16T11:48:55","slug":"lab-evo-fincarl","status":"publish","type":"track-record","link":"https:\/\/gvalex.it\/en\/track-record\/lab-evo-fincarl\/","title":{"rendered":"Lab Evo &#8211; Fincarl"},"content":{"rendered":"<p class=\"p1\">Our M&amp;A team assisted the majority shareholder of Lab Evo, an innovative start-up specialised in diagnostic and nutraceutical tools and services, in bringing Fincarl into the share capital, partly through a reserved capital increase and partly through share purchase.<\/p>","protected":false},"excerpt":{"rendered":"<p>Il nostro team di M&amp;A ha assistito il socio di maggioranza di Lab Evo, start-up innovativa specializzata in strumenti e servizi diagnostici e nutraceutici, nella complessa operazione che ha visto l\u2019ingresso di Fincarl nel capitale sociale di Lab Evo, avvenuta in parte mediante aumento di capitale riservato e, in parte, tramite l\u2019acquisto di una quota [&hellip;]<\/p>","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false},"tack-record-area-di-attivita":[36],"class_list":["post-4466","track-record","type-track-record","status-publish","hentry","tack-record-area-di-attivita-corporate-ma"],"acf":[],"_links":{"self":[{"href":"https:\/\/gvalex.it\/en\/wp-json\/wp\/v2\/track-record\/4466","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gvalex.it\/en\/wp-json\/wp\/v2\/track-record"}],"about":[{"href":"https:\/\/gvalex.it\/en\/wp-json\/wp\/v2\/types\/track-record"}],"wp:attachment":[{"href":"https:\/\/gvalex.it\/en\/wp-json\/wp\/v2\/media?parent=4466"}],"wp:term":[{"taxonomy":"tack-record-area-di-attivita","embeddable":true,"href":"https:\/\/gvalex.it\/en\/wp-json\/wp\/v2\/tack-record-area-di-attivita?post=4466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}